March 7, 2008 – CircuLite has advanced its Synergy Pocket Circulatory Assist Device clinical program into a 20-patient trial, after completion of a first-in-man pilot study of Synergy in four patients, as the company seeks CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients.
Siemens Healthcare now has available the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 7, 2008 - Siemens Healthcare launched the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 6, 2008 - Axellis Ltd., the UK- and US-based medical technology company, has completed acquisitions of three ...
March 5, 2008 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency ...
March 6, 2008 - The third annual Medical Device Regulatory, Reimbursement and Compliance Congress (Device Congress) to ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform to treat heart failure.
March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, marking the company�s seventh U.S. or European regulatory approval in the past nine weeks.
For patient monitoring systems not integrated with PiCCO-Technology, Pulsion Medical Systems offers the PiCCO parameters ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in Vancouver, British Columbia, marking the progression of minimally-invasive valve therapy.
March 4, 2008 – MEDRAD sales revenues grew to $525 million in 2007, an increase of 10 percent over the previous year, which is expected to grow further should the merger with Possis be completed.
Edwards Lifesciences provides The Vigilance II monitor, which is designed to gives users the ability to present complex ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 4, 2008 - By using a dual-source technique on a single computed tomography (CT) system, a research team at the ...
The new version of Visage CS Cardiac Analysis is said to feature a set of new tools and optimizations such as calcium scoring, enhanced reporting and manual editing of the left ventricle geometry. Visage CS Cardiac Analysis is designed to allow viewing and post-processing of even the largest multi-phase cardiac CT studies, using Visage’s server-based thin-client performance.
March 4, 2008 - Visage Imaging will unveil its Visage Thin Client solutions portfolio, and demonstrate scalability for ...